Abstract
The treatment of rectal cancer has undergone a tremendous surgical evolution over the past century. In the past three decades, transanal excision has emerged as a popular treatment option for T1 and selected T2 rectal adenocarcinomas, allowing less morbidity for early cancers. The surgical options offered to the patient are the Parks’ per anal excision and the transanal endoscopic microsurgery (TEM).
Similar content being viewed by others
References
Tytherleigh MG, Warren BF, Mortensen NJ (2008) Management of early rectal cancer. Br J Surg 95:409–423
Brown G, Davies S, Williams GT et al (2004) Effectiveness of preoperative staging in rectal cancer: digital rectal examination, endoluminal ultrasound or magnetic resonance imaging? Br J Cancer 91:23–29
Association of Coloproctology of Great Britain and Ireland (2007) Guidelines for the management of colorectal cancer, 3rd edn. http://www.library.nhs.uk/theatres/Viewresourse.aspx?resID=31479
Tepetes K, Spyridakis ME (2007) Local excision for early rectal cancer in the era of neoadjuvant strategies. Hepato Gastroenterol 54:1689–1693
Buess G (1993) Review: transanal endoscopic microsurgery (TEM). J R Coll Surg Edinb 38:239–245
Conflict of interest
The authors declare that there is no conflict of interest related to this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kesisoglou, I., Sapalidis, K. Treatment of early rectal cancer. Tech Coloproctol 14 (Suppl 1), 33–34 (2010). https://doi.org/10.1007/s10151-010-0640-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10151-010-0640-x